BRIEF-FDA approves Genentech's MS drug Ocrevus
* FDA approves Genentech's Ocrevus (ocrelizumab) for relapsing and primary progressive forms of multiple sclerosis
Nov 29 Britain's air crash investigation agency is sending a team of experts to Colombia to help the country's aviation authority investigate the crash of a regional jet that killed 75 people, a spokesman said.
The team of three investigators is expected to arrive at the scene of the crash on Wednesday, the spokesman for the Air Accidents Investigation Branch added.
The investigation will be led by Colombia's Aeronautica Civil, with Britain automatically involved as the country where the BAe 146 jet, also known as Avro RJ, was manufactured.
The British team includes experts in flight operations, engineering and flight data recorders, the spokesman added. (Reporting by Tim Hepher; Editing by Sudip Kar-Gupta)
LIMA, March 28 A Boeing jet operated by Peruvian Airlines caught fire on Tuesday while landing at an airport near the Andean town of Jauja in central Peru after it swerved on the runway, but there were no serious injuries, a government minister said.
March 28 The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay by regulators over manufacturing issues.